Cargando…
The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911550/ https://www.ncbi.nlm.nih.gov/pubmed/35268749 http://dx.doi.org/10.3390/molecules27051646 |
_version_ | 1784666841155633152 |
---|---|
author | Awahara, Chiyuki Oku, Daiki Furuta, Saki Kobayashi, Kazuya Teruya, Kenta Akaji, Kenichi Hattori, Yasunao |
author_facet | Awahara, Chiyuki Oku, Daiki Furuta, Saki Kobayashi, Kazuya Teruya, Kenta Akaji, Kenichi Hattori, Yasunao |
author_sort | Awahara, Chiyuki |
collection | PubMed |
description | In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors. |
format | Online Article Text |
id | pubmed-8911550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89115502022-03-11 The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease Awahara, Chiyuki Oku, Daiki Furuta, Saki Kobayashi, Kazuya Teruya, Kenta Akaji, Kenichi Hattori, Yasunao Molecules Article In this study, the effects of side-chain configurations of D-Ile residues of a retro–inverso (RI)-type inhibitor on the human T-cell leukemia virus type 1 (HTLV-1) protease containing a hydroxyethylamine dipeptide isostere were clarified. Prior to evaluation using the RI-type inhibitor, the effects of side-chain configurations of Ile residues of the substrate peptide on the HTLV-1 protease were examined to estimate the influence of side-chain configurations on enzyme activity. Based on the estimation of the influence of side-chain configurations on protease affinity, the RI-type inhibitors containing a D-allo-Ile residue in the corresponding substrate sequence, instead of a D-Ile residue, were synthesized via 9-fluorenylmethoxycarbonyl-based solid-phase peptide synthesis. Refolded recombinant HTLV-1 protease (1-116, L40I) was used for the simple and short evaluation of the inhibitory activities of the synthesized RI-type inhibitors. The results clearly indicated that mimicking the whole topology, comprising both the main- and side-chain structures of the parent inhibitor, is effective for the design of potent RI-modified protease inhibitors. MDPI 2022-03-02 /pmc/articles/PMC8911550/ /pubmed/35268749 http://dx.doi.org/10.3390/molecules27051646 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Awahara, Chiyuki Oku, Daiki Furuta, Saki Kobayashi, Kazuya Teruya, Kenta Akaji, Kenichi Hattori, Yasunao The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_full | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_fullStr | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_full_unstemmed | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_short | The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease |
title_sort | effects of side-chain configurations of a retro–inverso-type inhibitor on the human t-cell leukemia virus (htlv)-1 protease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911550/ https://www.ncbi.nlm.nih.gov/pubmed/35268749 http://dx.doi.org/10.3390/molecules27051646 |
work_keys_str_mv | AT awaharachiyuki theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT okudaiki theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT furutasaki theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kobayashikazuya theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT teruyakenta theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT akajikenichi theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT hattoriyasunao theeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT awaharachiyuki effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT okudaiki effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT furutasaki effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT kobayashikazuya effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT teruyakenta effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT akajikenichi effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease AT hattoriyasunao effectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1protease |